EUVIMEDEUVIMED entdecken
Open Access · CC0

Intrapartum oral azithromycin versus placebo alone or in combination with other antimicrobials on maternal infection in South East Asia

Archana B. Patel, Kunal Kurhe, Savita Bhargav, Vaishali Khedikar, Manjushri Waikar, Poonam Shivkumar, Shivaprasad S. Goudar, Mrityunjay C. Metgud, Avinash Kavi, Richard Derman, Rashidul Haque, Sk Masum Billah und 14 weitere

PLOS One · 18.11.2026 · 21 (11) · e0346359

DOI: 10.1371/journal.pone.0346359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.11.2026. Verfasst von Archana B. Patel und 25 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Bill and Melinda Gates Foundation, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In low-resource facilities that routinely use intrapartum prophylactic antimicrobials, the use of multiple antimicrobials could be rationalised by a single oral dose of oral azithromycin.

Methods

The Azithromycin Prevention in Labor Use Study (A-PLUS), a randomized double-blind, placebo-controlled trial performed across eight sites in seven countries amongst women who planned to deliver vaginally. They were randomly assigned to receive study drug, a single intrapartum 2 gm oral dose of azithromycin or an identical appearing placebo. Data from four South-East Asia sites (Indian sites Nagpur and Belagavi, Pakistan, and Bangladesh) was analyzed to evaluate whether the use of non-study antimicrobials (alone or in-combination) given after randomization through one-day postpartum for any indication (prophylactic or treatment) modified the effect of study drugs on maternal outcomes (maternal infections, antibiotic usage 2–42days postpartum on ambulatory basis or re-hospitalization). The non-study antimicrobials given after randomization through 1-day postpartum was defined by four exposure sub-groups within azithromycin and placebo arm as, Use of: i) No non-study antibiotic; ii) Cephalosporin only; iii) Other non-study non-cephalosporin antibiotics; and iv) Cephalosporin and other non-study non-cephalosporin antibiotics. An intent to treat (ITT) analysis was adopted. Adjusted relative risks and 95% confidence intervals comparing azithromycin with placebo were estimated using Poisson regression models with robust variance estimators that included study site, maternal non-study antimicrobial use, and a treatment-by-non-study antimicrobial use interaction term.

Results

All maternal non-study antibiotic subgroups had balanced randomization between azithromycin and placebo. The risk of any maternal infections was reduced when only azithromycin was received versus placebo (RR = 0.75; 95% CI-0.57–0.98) and when group iv antimicrobials were used with azithromycin compared to only group iv antimicrobials (RR = 0.79; 95% CI-0.66–0.95). The use of antibiotics from day2–42 was similar in both arms (azithromycin or placebo) with or without use of other antimicrobials.

Conclusions

This secondary analysis found no evidence that non-study antimicrobials use modified the effect of azithromycin on maternal outcomes. This study underscores the importance of considering an easily administrable intrapartum prophylaxis of oral monotherapy in low resource, high risk for infections sites to reduce antimicrobial resistance due to multiple antimicrobial use.

Förderung

  • Bill and Melinda Gates Foundation
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Patel, A. B., Kurhe, K., Bhargav, S., Khedikar, V., Waikar, M., Shivkumar, P., Goudar, S. S., Metgud, M. C., Kavi, A., Derman, R., Haque, R., Billah, S. M., Petri, W., Saleem, S., Jessani, S., Tikmani, S. S., Goldenberg, R. L., Hemingway-Foday, J. J., Koso-Thomas, M., …, & Hibberd, P. L. (2026). Intrapartum oral azithromycin versus placebo alone or in combination with other antimicrobials on maternal infection in South East Asia. PLOS One, 21(11), e0346359. https://doi.org/10.1371/journal.pone.0346359

Vancouver

Patel AB, Kurhe K, Bhargav S, Khedikar V, Waikar M, Shivkumar P, et al. Intrapartum oral azithromycin versus placebo alone or in combination with other antimicrobials on maternal infection in South East Asia. PLOS One. 2026;21(11):e0346359. doi:10.1371/journal.pone.0346359

BibTeX
@article{Patel2026,
  author = {Patel, Archana B. and Kurhe, Kunal and Bhargav, Savita and Khedikar, Vaishali and Waikar, Manjushri and Shivkumar, Poonam and Goudar, Shivaprasad S. and Metgud, Mrityunjay C. and Kavi, Avinash and Derman, Richard and Haque, Rashidul and Billah, Sk Masum and Petri, William and Saleem, Sarah and Jessani, Saleem and Tikmani, Shiyam Sunder and Goldenberg, Robert L. and Hemingway-Foday, Jennifer J. and Koso-Thomas, Marion and Tita, Alan T. N. and Carlo, Waldemar A. and Moore, Janet L. and Babineau, Denise C. and Nielsen, Eleanor and McClure, Elizabeth M. and Hibberd, Patricia L.},
  title = {Intrapartum oral azithromycin versus placebo alone or in combination with other antimicrobials on maternal infection in South East Asia},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0346359},
  doi = {10.1371/journal.pone.0346359}
}
Kostenlos starten →